Nobuhiro Hashimoto, Yusuke Sakaguchi, Miyu Naito, Syuzo Makino, Akito Takashima, Hiromitsu Miyakawa et al. Hyperkalemia risk and potassium trajectory after finerenone initiation: a real-world cohort study. // Clinical and Experimental Nephrology. – 2026. – DOI: 10.1007/s10157-026-02898-7. – URL: https://doi.org/10.1007/s10157-026-02898-7
Nobuhiro Hashimoto, Yusuke Sakaguchi, Miyu Naito, Syuzo Makino, Akito Takashima, Hiromitsu Miyakawa, Hiroki Okushima, Mitsutoshi Asai, & Terumasa Hayashi (2026). Hyperkalemia risk and potassium trajectory after finerenone initiation: a real-world cohort study. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-026-02898-7
Nobuhiro Hashimoto, et al. “Hyperkalemia risk and potassium trajectory after finerenone initiation: a real-world cohort study.” Clinical and Experimental Nephrology, 2026. doi:10.1007/s10157-026-02898-7.
@article{Hashimoto2026,
title = {Hyperkalemia risk and potassium trajectory after finerenone initiation: a real-world cohort study},
author = {Hashimoto, Nobuhiro and Sakaguchi, Yusuke and Naito, Miyu and Makino, Syuzo and Takashima, Akito and Miyakawa, Hiromitsu and Okushima, Hiroki and Asai, Mitsutoshi and Hayashi, Terumasa},
journal = {Clinical and Experimental Nephrology},
year = {2026},
doi = {10.1007/s10157-026-02898-7},
url = {https://doi.org/10.1007/s10157-026-02898-7}
}